Suzuki Y - Search Results

1

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, Kobayashi M, Tsubota A, Nakamura I, Murashima N, Kumada H, Kawanishi M. Ikeda K, et al. Among authors: suzuki y. Hepatology. 1999 Apr;29(4):1124-30. doi: 10.1002/hep.510290439. Hepatology. 1999. PMID: 10094956

2

Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers.

Tsubota A, Kumada H, Takaki K, Chayama K, Kobayashi M, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Murashima N, Ikeda K. Tsubota A, et al. Among authors: suzuki y. J Med Virol. 1998 Dec;56(4):287-93. doi: 10.1002/(sici)1096-9071(199812)56:4<287::aid-jmv1>3.0.co;2-p. J Med Virol. 1998. PMID: 9829631

3

Relationship of angiographic finding with neovascular structure detected by immunohistochemical staining of alpha-smooth muscle actin in small hepatocellular carcinoma.

Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Kobayashi M, Arase Y, Chayama K, Murashima N, Kumada H. Ikeda K, et al. Among authors: suzuki y. J Gastroenterol Hepatol. 1998 Dec;13(12):1266-73. J Gastroenterol Hepatol. 1998. PMID: 9918437

4

[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly].

Hoshida Y, Ikeda K, Saito S, Kobayashi M, Kobayashi M, Suzuki Y, Tsubota A, Koida I, Arase Y, Murashima N, Chayama K, Kumada H. Hoshida Y, et al. Among authors: suzuki y. Nihon Shokakibyo Gakkai Zasshi. 1999 Feb;96(2):142-6. Nihon Shokakibyo Gakkai Zasshi. 1999. PMID: 10087885 Clinical Trial. Japanese.

5

Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha.

Kobayashi M, Chayama K, Arase Y, Tsubota A, Saitoh S, Suzuki Y, Kobayashi M, Kobayashi M, Ikeda K, Matsuda M, Koike H, Hashimoto M, Kumada H. Kobayashi M, et al. Among authors: suzuki y. J Gastroenterol. 1999 Feb;34(1):94-9. doi: 10.1007/s005350050222. J Gastroenterol. 1999. PMID: 10204617

6

Prevalence of TT virus before and after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma.

Kobayashi M, Chayama K, Arase Y, Kobayashi M, Tsubota A, Suzuki Y, Koida I, Saitoh S, Murashima N, Ikeda K, Koike H, Hashimoto M, Kobayashi M, Kumada H. Kobayashi M, et al. Among authors: suzuki y. J Gastroenterol Hepatol. 1999 Apr;14(4):358-63. doi: 10.1046/j.1440-1746.1999.01860.x. J Gastroenterol Hepatol. 1999. PMID: 10207786

7

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection.

Suzuki Y, Kumada H, Ikeda K, Chayama K, Arase Y, Saitoh S, Tsubota A, Kobayashi M, Koike M, Ogawa N, Tanikawa K. Suzuki Y, et al. J Hepatol. 1999 May;30(5):743-8. doi: 10.1016/s0168-8278(99)80123-8. J Hepatol. 1999. PMID: 10365796 Clinical Trial.

8

Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA.

Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Kobayashi M, Kumada H. Arase Y, et al. Among authors: suzuki y. Intern Med. 1999 Jun;38(6):461-6. doi: 10.2169/internalmedicine.38.461. Intern Med. 1999. PMID: 10411349 Free article. Clinical Trial.

9

Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.

Tsubota A, Kumada H, Arase Y, Chayama K, Saitoh S, Ikeda K, Kobayashi M, Suzuki Y, Murashima N. Tsubota A, et al. Among authors: suzuki y. Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1077-83. doi: 10.1097/00042737-199910000-00002. Eur J Gastroenterol Hepatol. 1999. PMID: 10524635 Clinical Trial.

10

Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy.

Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Nakamura I, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Kobayashi M, Kumada H. Arase Y, et al. Among authors: suzuki y. J Gastroenterol. 1999 Oct;34(5):594-9. doi: 10.1007/s005350050378. J Gastroenterol. 1999. PMID: 10535487 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,409 results

Search Page